ALLO
Allogene Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.22
+0.09 (+4.23%)
Rating:C-
Company Profile
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.15
Prev. Close
$2.13
Day Low
$2.13
Day High
$2.24
52W Low
$0.98
52W High
$4.46
Market Cap
$0.54B
Volume
14.64M